The Retrotransposon-STING Decoupling Hypothesis: Noncanonical Signaling as a Failed Adaptation to Chronic Genomic Parasite Reactivation
We usually think of genomic aging as a simple loss of information, where our DNA "blueprints" just wear out over time. However, growing evidence suggests that vascular senescence might actually be driven by the reactivation of ancient genomic parasites—specifically transposable elements (TEs) like LINE-1. These repetitive sequences make up over 45% of the human genome, and while they’re typically kept under wraps by methylation and dense heterochromatin, that control slips as we age. My hypothesis is that vascular aging results from a failed cellular compromise: a shift from canonical to noncanonical STING signaling triggered by the chronic accumulation of TE-derived cytosolic DNA.
In young cells, the cGAS-STING pathway acts as a sharp viral sensor. Once it spots foreign DNA, cGAS generates cGAMP, which sets off STING phosphorylation and an IRF3-mediated interferon response [Frontiers in CV Med 2025]. But as epigenetic silencing fails in older cells, they're inundated with endogenous retrotransposon cDNA. I’d argue that the noncanonical STING signaling found in senescent cells—marked by lower cGAMP levels and dampened STING phosphorylation [PNAS 2024]—isn't just a glitch. It’s likely an adaptation I call "Signal Saturation Fatigue" (SSF). To keep from hitting the self-destruct button (apoptosis or pyroptosis) under the weight of this massive internal "viral load," the cell throttles its canonical cGAS-STING axis.
This survival tactic backfires, creating a "zombie state" with several consequences:
- Persistent Sterile Inflammation: Noncanonical STING keeps driving NF-κB and the Senescence-Associated Secretory Phenotype (SASP) without actually triggering the mechanisms to clear the dead cells.
- HIF-1α Destabilization: This background noise destabilizes HIF-1α [FightAging 2020], which ruins the metabolic flexibility endothelial cells need for repair and angiogenesis.
- Vascular Rigidity: The resulting SASP breaks down the extracellular matrix and kills off NO-dependent vasodilation. While cGAS inhibition might fix this in the early stages, the damage becomes much harder to reverse once that noncanonical switch is flipped [PMC9662267].
In this context, the vascular endothelium—with its massive surface area and sensitivity to systemic danger signals—is the main casualty in the genome's internal war. The genetic archive stops being a guide and starts being a source of constant interference. This noncanonical pathway lets senescent vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) linger in a pro-inflammatory state, leading to the unstable plaques and failed angiogenesis typical of the aging vasculature [Frontiers in CV Med 2025].
To see if this holds up, we could quantify TE-cDNA levels in aged human ECs to see if the concentration of LINE-1 DNA correlates with the shift from p-STING to noncanonical signaling. We could also try pharmacological reversal; using reverse transcriptase inhibitors like Lamivudine in old mice would tell us if lowering the "parasite load" can bring back canonical STING sensitivity or dampen the SASP. Finally, the hypothesis would be falsified if chronic exposure to external viral DNA doesn't trigger this same noncanonical transition, suggesting the shift isn't a specific adaptation to internal TE-load.